Since that time, many groups have independently confirmed these observations (recently meta-analyzed by Krei et al. [7] and further reinforced the remarkable association of increased levels of IL-18 for SJIA and highly-similar diseases at risk for MAS [4, 7–9]. This evidence concerns the gene IL18 and macrophage activation syndrome.